FDA Investigator David J Gallant
David J Gallant has inspections in 3 countries as of 28 Oct 2022. David J Gallant has collaborated with a combined 355 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
28 Oct 2022
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Japan,
Taiwan
Co-Investigator(s):
Charles L Larson,
Cynthia A Harris, MD, RN,
Cynthia L Gorveatt,
Daniel T Lee,
Emmanuel A Dimaano, Jr,
Evelyn Taha,
Jacob M Dyer,
James A Beaulieu,
Janete F Guardia,
Joseph A Morkunas,
Jude C Dikes,
Kelvin Cheung,
Linda Agregory Duty,
Lindsey L Kirsh,
Lori S Lawless,
Marc S Neubauer,
Marcus A Ray,
Merideth K Rose,
Stanley B Eugene, BS, BME,
Vivian Garcia
David J Gallant's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2000 | FDA 483 Response | Nihon Kohden Tomioka Corporation - Form 483R, 2000-08-30 |
July, 2000 | EIR | Terumo Medical Corporation - EIR, 2000-07-26 |
June, 2000 | EIR | Nihon Kohden Tomioka Corporation - EIR, 2000-06-08 |
June, 2000 | FDA 483 | Nihon Kohden Corporation - Form 483, 2000-06-08 |
July, 2000 | FDA 483 | Terumo Medical Corporation - Form 483, 2000-07-26 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more